# clm_B61AEABD9233

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: cash_and_equivalents  
value: 325,286,000 United States dollar  
valid_from: 2010-09-30  
valid_to: 2010-12-31  
published: 2010-10-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_25FEBCAE80F4  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals cash and equivalents: 325,286,000 United States dollar", as of 2010-09-30 (until 2010-12-31). Claim clm_B61AEABD9233, https://asof.is/claim/clm_B61AEABD9233, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-10-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm (primary, SEC EDGAR 10-Q Q3 FY2010, published 2010-10-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 112,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_B61AEABD9233](/claim/clm_B61AEABD9233.md) | [clm_BBF34107EC0B](/claim/clm_BBF34107EC0B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.